Literature DB >> 8579216

Non-radioactive DNA diagnosis for the fragile X syndrome in mentally retarded Japanese males.

E Nanba1, Y Kohno, A Matsuda, M Yano, C Sato, K Hashimoto, T Koeda, K Yoshino, M Kimura, Y Maeoka.   

Abstract

A rapid screening test was developed to detect CGG repeat expansion of the FMR-1 gene causing the fragile X syndrome by a non-radioisotope PCR technique. A biotin-labeled primer was initially used and the biotin-labeled PCR product was detected by means of chemiluminescence. The normal PCR product of around 300 bp was not created in the abnormal FMR-1 gene sample with this method. Four positive samples were found among those from 226 mentally retarded males, but the CGG repeat expansion was shown on Southern blot analysis in only one sample. To eliminate false-positive samples, a hybridization method involving a biotin-labeled (CGG)s oligonucleotide was developed for the PCR product and the CGG repeat expansion could be detected. Finally, 256 mentally retarded males in Japan were examined and only 2 abnormal samples were detected. The prevalence of this abnormality was less than 1%, which is relatively lower than those reported previously.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8579216     DOI: 10.1016/0387-7604(95)00031-6

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  5 in total

1.  Expansion of genetic testing in the division of functional genomics, research center for bioscience and technology, tottori university from 2000 to 2013.

Authors:  Kaori Adachi
Journal:  Yonago Acta Med       Date:  2014-04-28       Impact factor: 1.641

Review 2.  Fragile X syndrome: the FMR1 CGG repeat distribution among world populations.

Authors:  Emmanuel Peprah
Journal:  Ann Hum Genet       Date:  2011-12-21       Impact factor: 1.670

Review 3.  FMR1 and the fragile X syndrome: human genome epidemiology review.

Authors:  D C Crawford; J M Acuña; S L Sherman
Journal:  Genet Med       Date:  2001 Sep-Oct       Impact factor: 8.822

4.  Clinical Characteristics of Fragile X Syndrome Patients in Japan.

Authors:  Tetsuya Okazaki; Kaori Adachi; Kaori Matsuura; Yoshitaka Oyama; Madoka Nose; Emi Shirahata; Toshiaki Abe; Takeshi Hasegawa; Toshiro Maihara; Yoshihiro Maegaki; Eiji Nanba
Journal:  Yonago Acta Med       Date:  2021-01-06       Impact factor: 1.641

5.  Cascade Screening for Fragile X Syndrome/CGG Repeat Expansions in Children Attending Special Education in Sri Lanka.

Authors:  C H W M R Bhagya Chandrasekara; W S Sulochana Wijesundera; Hemamali N Perera; Samuel S Chong; Indhu-Shree Rajan-Babu
Journal:  PLoS One       Date:  2015-12-22       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.